Discovery and development of ACE inhibitors
Discovery and development of ACE inhibitors
The discovery and development of ACE inhibitors (Angiotensin-Converting Enzyme inhibitors) represent a significant advancement in the field of cardiovascular medicine. ACE inhibitors are a class of medication primarily used for the treatment of hypertension (high blood pressure) and congestive heart failure.
History[edit | edit source]
The journey to the discovery of ACE inhibitors began with the study of the renin-angiotensin system (RAS), a hormone system that regulates blood pressure and fluid balance. In the 1950s, researchers identified the role of angiotensin II, a potent vasoconstrictor, in increasing blood pressure. The enzyme responsible for converting angiotensin I to angiotensin II was named angiotensin-converting enzyme (ACE).
In the 1960s, Brazilian scientist Sérgio Henrique Ferreira discovered a peptide in the venom of the Bothrops jararaca snake that inhibited the action of ACE. This peptide, known as bradykinin potentiating factor (BPF), laid the groundwork for the development of synthetic ACE inhibitors.
Development[edit | edit source]
The first synthetic ACE inhibitor, captopril, was developed in the late 1970s by researchers at Squibb Corporation (now part of Bristol-Myers Squibb). Captopril was approved by the Food and Drug Administration (FDA) in 1981 for the treatment of hypertension. Its success led to the development of other ACE inhibitors, including enalapril, lisinopril, and ramipril.
Mechanism of Action[edit | edit source]
ACE inhibitors work by inhibiting the activity of the angiotensin-converting enzyme, which decreases the production of angiotensin II. This results in the dilation of blood vessels, reduced blood pressure, and decreased workload on the heart. Additionally, ACE inhibitors increase the levels of bradykinin, a peptide that promotes vasodilation.
Clinical Uses[edit | edit source]
ACE inhibitors are used to treat a variety of cardiovascular conditions, including:
- Hypertension
- Congestive heart failure
- Chronic kidney disease
- Diabetic nephropathy
- Post-myocardial infarction
Side Effects[edit | edit source]
Common side effects of ACE inhibitors include:
- Cough
- Hyperkalemia (elevated potassium levels)
- Hypotension (low blood pressure)
- Angioedema (swelling of deeper layers of the skin)
Related Pages[edit | edit source]
- Renin-angiotensin system
- Hypertension
- Congestive heart failure
- Captopril
- Enalapril
- Lisinopril
- Ramipril
References[edit | edit source]
External Links[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD